Skye Bioscience Long Term Deferred Assets (Quarterly) Analysis

Skye Bioscience, Inc. (SKYE)

0.9737 -0.03 (-2.63%) USD | NASDAQ | Jan 20, 16:00

1.00 +0.03 (+2.70%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for SKYE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Perspective Therapeutics, Inc.	--
Theravance Biopharma, Inc.	--
Viking Therapeutics, Inc.	Upgrade
Kyntra Bio, Inc.	--
Myomo, Inc.	--